Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Álvaro López Masjuan"'
Autor:
Pablo Moriña-Vázquez, María Teresa Moraleda-Salas, Álvaro López-Masjuan-Ríos, Irene Esteve-Ruiz, Álvaro Arce-León, Carmen Lluch-Requerey, Adrián Rodríguez-Albarrán, José Venegas-Gamero, Antonio Enrique Gómez-Menchero
Publikováno v:
Journal of Interventional Cardiac Electrophysiology.
Autor:
Martino Pepe, Rodolfo Romero, Francisco Marín, Álvaro López-Masjuan, Juan García-Prieto, Marcos García-Aguado, Javier Elola, Antonio Fernández-Ortiz, Hope Covid Investigators, Carolina Espejo, Sergio Raposeiras-Roubín, Víctor Manuel Becerra-Muñoz, Christoph Liebetrau, Ivan Olier, Carlos Macaya, Jorge Luis Jativa Mendez, Charbel Maroun-Eid, Elvira Bondia, Alex F Castro-Mejía, Enrico Cerrato, Adelina Gonzalez, Javier López-Pais, Inmaculada Fernández-Rozas, Aitor Uribarri, Fabrizio Ugo, Harish Ramakrishna, Iván J. Núñez-Gil, María C Viana-Llamas, Mohammad Abumayyaleh, Miguel Corbí-Pascual, Gisela Feltes, Emilio Alfonso-Rodríguez, Vicente Estrada
Publikováno v:
American Heart Journal
AMERICAN HEART JOURNAL
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
AMERICAN HEART JOURNAL
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Background The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. Methods HOPE-COVID-19 (NCT04334291) is an international investigator-
Autor:
Ivan J. Núñez-Gil, Gisela Feltes, María C. Viana-Llamas, Sergio Raposeiras-Roubin, Rodolfo Romero, Emilio Alfonso-Rodríguez, Aitor Uribarri, Francesco Santoro, Víctor Becerra-Muñoz, Martino Pepe, Alex F. Castro-Mejía, Jaime Signes-Costa, Adelina Gonzalez, Francisco Marín, Javier Lopez-País, Enrico Cerrato, Olalla Vázquez-Cancela, Carolina Espejo-Paeres, Álvaro López Masjuan, Lazar Velicki, Ibrahim El-Battrawy, Harish Ramakrishna, Antonio Fernandez-Ortiz, Julián Perez-Villacastín
Publikováno v:
Scientia
Journal of Clinical Medicine; Volume 12; Issue 2; Pages: 706
Journal of Clinical Medicine; Volume 12; Issue 2; Pages: 706
COVID-19; Heart disease; Persistent COVID 19; Malaltia cardíaca; Persistent COVID-19; Enfermedad cardíaca; Persistente Background: Heart disease is linked to worse acute outcomes after coronavirus disease 2019 (COVID-19), although long-term outcome
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruíz, Irene María Esteve, Salas, María Teresa Moraleda, Ríos, Álvaro López-Masjuán, León, Álvaro Arce, Gamero, José Venegas, Gómez, Juan Manuel Fernández, Vázquez, Pablo Moriña
Publikováno v:
In REC: CardioClinics February 2023 58 Supplement 3:S35-S36
Autor:
Ríos, Álvaro López-Masjuán, Ruíz, Irene María Esteve, Salas, María Teresa Moraleda, León, Álvaro Arce, Vázquez, Pablo Moriña
Publikováno v:
In REC: CardioClinics February 2023 58 Supplement 3:S19-S19
Autor:
Polavieja, José Ignacio Morgado García de, Ríos, Álvaro López-Masjuán, Albarran, Adrian Rodríguez, Fernandez, José Francisco Diaz, Justel, Antonio León
Publikováno v:
In REC: CardioClinics February 2023 58 Supplement 2:S7-S7
Autor:
Mohammad Abumayyaleh, Iván J. Núñez Gil, María C. Viana-LLamas, Sergio Raposeiras Roubin, Rodolfo Romero, Emilio Alfonso-Rodríguez, Aitor Uribarri, Gisela Feltes, Víctor Manuel Becerra-Muñoz, Francesco Santoro, Martino Pepe, Alex Fernando Castro Mejía, Jaime Signes-Costa, Adelina Gonzalez, Francisco Marín, Javier López-País, Edoardo Manzone, Olalla Vazquez Cancela, Carolina Espejo Paeres, Alvaro López Masjuan, Lazar Velicki, Christel Weiß, David Chipayo, Antonio Fernandez-Ortiz, Ibrahim El-Battrawy, Ibrahim Akin, HOPE COVID-19 investigators
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundDiabetes mellitus (DM) is one of the most frequent comorbidities in patients suffering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a higher rate of severe course of coronavirus disease (COVID-19). However, data ab
Externí odkaz:
https://doaj.org/article/b3e3d959a20d4fb293560d2e109bb19f
Autor:
Francesco Santoro, Ivan J. Núñez‐Gil, Enrica Vitale, María C. Viana‐Llamas, Rodolfo Romero, Charbel Maroun Eid, Gisela Feltes Guzman, Victor Manuel Becerra‐Muñoz, Inmaculada Fernández Rozas, Aitor Uribarri, Emilio Alfonso‐Rodriguez, Marcos García Aguado, Jia Huang, Alex Fernando Castro Mejía, Juan Fortunato Garcia Prieto, Javier Elola, Fabrizio Ugo, Enrico Cerrato, Jaime Signes‐Costa, Sergio Raposeiras Roubin, Jorge Luis Jativa Mendez, Carolina Espejo Paeres, Alvaro López Masjuan, Francisco Marin, Federico Guerra, Ibrahim El‐Battrawy, Bernardo Cortese, Harish Ramakrishna, Julian Perez‐Villacastín, Antonio Fernandez‐Ortiz, Natale Daniele Brunetti
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 13 (2022)
Background COVID‐19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID‐19. The aim of this study was to evaluate sa
Externí odkaz:
https://doaj.org/article/f36de0aed6164c8eaf19c8288c3ee9ca